Pharma Leaders

sa-mRNA COVID-19 Vaccine Study Demonstrates Longer Protection Against Virus Compared to Other Vaccine Types

CSL and Artcurus announced the results of a study on the self-amplifying RNA vaccine.

CSL and Artcurus announced the results of a study on the self-amplifying RNA vaccine.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]